Arvinas (ARVN) stock faces a downgrade after underwhelming trial data for breast cancer drug vepdegestrant developed with ...

As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...

Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The ...

Investors should also remember that disruptive cycles tend to face skepticism before the fundamentals take over, and this AI ...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...

On Tuesday, president Donald Trump appeared in front of the White House as part of a bizarre sales pitch for Elon Musk's ...

U.S. President Donald Trump has stirred controversy by purchasing a Tesla vehicle in a show of support for Elon Musk.

While Tesla CEO Elon Musk isn't in any danger of struggling to make ends meet, his wealth has taken a significant hit recently as shares of the electric vehicle company tumble on the stock market.

Tech stocks like Nvidia tended to rise on the inflation news as odds of the Federal Reserve (Fed) cutting interest rates are now moved up on the calendar. The NASDAQ Composite advanced 1.2%, but the ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...

Musk pumped $270 million into Trump’s campaign heading into the 2024 election, appeared on stage with him and cheered Trump’s ...

Tesla’s stock began rising from the opening Tuesday after Trump posted overnight on his Truth Social platform that Musk was “putting it on the line” to help the country. Trump claimed in the post that ...